Review Article

You have full text access to this OnlineOpen article

Breast cancer in sub-Saharan Africa: How does it relate to breast cancer in African-American women?

  1. Alero Fregene M.D.,
  2. Lisa A. Newman M.D., M.P.H.†,*

Article first published online: 14 MAR 2005

DOI: 10.1002/cncr.20978

Issue

Cancer

Cancer

Volume 103, Issue 8, pages 1540–1550, 15 April 2005

Additional Information

How to Cite

Fregene, A. and Newman, L. A. (2005), Breast cancer in sub-Saharan Africa: How does it relate to breast cancer in African-American women?. Cancer, 103: 1540–1550. doi: 10.1002/cncr.20978

Author Information

  1. Department of Surgery, University of Michigan Comprehensive Cancer Center, University of Michigan, Ann Arbor, Michigan

  1. †

    Fax: 734-647-9647

*University of Michigan, 1500 East Medical Center Drive, 3308 CGC, Ann Arbor, MI 48109

Publication History

  1. Issue published online: 4 APR 2005
  2. Article first published online: 14 MAR 2005
  3. Manuscript Accepted: 20 DEC 2004
  4. Manuscript Revised: 2 NOV 2004
  5. Manuscript Received: 8 SEP 2004

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (234K)

REFERENCES

  • 1
    Ries L, Eisner M, Kosary C, Hankey B, Miller B, Clegg L, et al. SEER cancer statistics review, 1975–2001. Vol. 2004. URL: http://seer.cancer.gov/csr/1975_2001/. [Accession date, 2004].
  • 2
    Li CI, Malone KE, Daling JR. Differences in breast cancer hormone receptor status and histology by race and ethnicity among women 50 years of age and older. Cancer Epidemiol Biomarkers Prev. 2002; 11: 601–607.
  • 3
    Li CI, Malone KE, Daling JR. Differences in breast cancer stage, treatment, and survival by race and ethnicity. Arch Intern Med. 2003; 163: 49–56.
  • 4
    Newman LA, Bunner S, Carolin K, Bouwman D, Kosir MA, White M, et al. Ethnicity related differences in the survival of young breast carcinoma patients. Cancer 2002; 95: 21–27.
    Direct Link:
  • 5
    Shavers VL, Harlan LC, Stevens JL. Racial/ethnic variation in clinical presentation, treatment, and survival among breast cancer patients under age 35. Cancer. 2003; 97: 134–147.
    Direct Link:
  • 6
    Jones B, Kasl S, Howe C, Lachman M, Dubrow R, Curnen M, et al. African American/White differences in breast carcinoma: p53 alterations and other tumor characteristics. Cancer. 2004; 101: 1293–1301.
    Direct Link:
  • 7
    Porter PL, Lund MJ, Lin MG, Yuan X, Liff JM, Flagg EW, et al. Racial differences in the expression of cell cycle-regulatory proteins in breast carcinoma. Cancer. 2004; 100: 2533–2542.
    Direct Link:
  • 8
    Elledge RM, Clark GM, Chamness GC, Osborne CK. Tumor biologic factors and breast cancer prognosis among white, Hispanic, and black women in the United States. J Natl Cancer Inst. 1994; 86: 705–712.
  • 9
    Salas A, Richards M, Lareu MV, Scozzari R, Coppa A, Torroni A, et al. The African diaspora: mitochondrial DNA and the Atlantic slave trade. Am J Hum Genet. 2004; 74: 454–465.
  • 10
    Sandelin K, Apffelstaedt JP, Abdullah H, Murray EM, Ajuluchuku EU. Breast surgery international—breast cancer in developing countries. Scand J Surg. 2002; 91: 222–226.
  • 11
    International Agency for Research on Cancer. Globocan 2000: cancer incidence, mortality and prevalence worldwide. Lyon, France: IARC Press. 2001.
  • 12
    Hoffman M, de Pinho H, Cooper D, Sayed R, Dent DM, Gudgeon A, et al. Breast cancer incidence and determinants of cancer stage in the Western Cape. S Afr Med J. 2000; 90: 1212–1216.
  • 13
    Vorobiof DA, Sitas F, Vorobiof G. Breast cancer incidence in South Africa. J Clin Oncol. 2001; 19(18 Suppl ): 125S–127S.
  • 14
    Uganda Breast Cancer Working Group. Breast cancer guidelines for Uganda. Afr Health Sci. 2003; 3: 47–50.
  • 15
    Parkin DM. Cancer in developing countries. Cancer Surv. 1994; 19–20: 519–561.
  • 16
    Amir H, Kitinya JN, Parkin DM. A comparative study of carcinoma of the breast in an African population. East Afr Med J. 1994; 71: 215–218.
  • 17
    Anyanwu SN. Breast cancer in eastern Nigeria: a ten year review. West Afr J Med. 2000; 19: 120–125.
  • 18
    Hassan I, Onukak EE, Mabogunje OA. Breast cancer in Zaria, Nigeria. J R Coll Surg Edinb. 1992; 37: 159–161.
  • 19
    Muguti GI. Experience with breast cancer in Zimbabwe. J R Coll Surg Edinb. 1993; 38: 75–78.
  • 20
    Amir H, Makwaya CK, Aziz MR, Jessani S. Breast cancer and risk factors in an African population: a case referent study. East Afr Med J. 1998; 75: 268–270.
  • 21
    Adebamowo CA, Ogundiran TO, Adenipekun AA, Oyesegun RA, Campbell OB, Akang EU, et al. Obesity and height in urban Nigerian women with breast cancer. Ann Epidemiol. 2003; 13: 455–461.
  • 22
    Yawitch TM, van Rensburg EJ, Mertz M, Falkson CI. Absence of commonly recurring BRCA1 mutations in black South African women with breast cancer. S Afr Med J. 2000; 90: 788.
  • 23
    Ihekwaba FN. Breast cancer in Nigerian women. Br J Surg. 1992; 79: 771–775.
    Direct Link:
  • 24
    Muthuphei MN. Carcinoma of the breast at Ga-Rankuwa Hospital histopathology laboratory (South Africa). Cent Afr J Med. 1994; 40: 254–257.
  • 25
    Adebamowo CA, Ajayi OO. Breast cancer in Nigeria. West Afr J Med. 2000; 19: 179–191.
  • 26
    World Health Organization. Life tables for 191 countries: world mortality in 2000. URL: http://www3.who.int/whosis/life/life_tables/life_tables.cfm?path=whosis,burden_statistics,life,life_tables&language=English. [Accession date, 2000].
  • 27
    Jones SB. Cancer in the developing world: a call to action. BMJ. 1999; 319: 505–508.
  • 28
    World Health Organization. Mortality by sex, cause, and WHO region, estimates for 1998. In: The World Health Organization Report 1999. Making a difference. Geneva, Switzerland: World Health Organization. 1999.
  • 29
    Rosenberg L, Kelly JP, Shapiro S, Hoffman M, Cooper D. Risk factors for breast cancer in South African women. S Afr Med J. 2002; 92: 447–448.
  • 30
    Parkin DM, Vizcaino AP, Skinner ME, Ndhlovu A. Cancer patterns and risk factors in the African population of southwestern Zimbabwe, 1963–1977. Cancer Epidemiol Biomarkers Prev. 1994; 3: 537–547.
  • 31
    Strassmann BI. Menstrual cycling and breast cancer: an evolutionary perspective. J Womens Health. 1999; 8: 193–202.
  • 32
    Coogan PF, Rosenberg L, Shapiro S, Hoffman M. Lactation and breast carcinoma risk in a South African population. Cancer. 1999; 86: 982–989.
    Direct Link:
  • 33
    Djuric Z, Depper JB, Uhley V, Smith D, Lababidi S, Martino S, et al. Oxidative DNA damage levels in blood from women at high risk for breast cancer are associated with dietary intakes of meats, vegetables, and fruits. J Am Diet Assoc. 1998; 98: 524–528.
  • 34
    Boyd NF, Stone J, Vogt KN, Connelly BS, Martin LJ, Minkin S. Dietary fat and breast cancer risk revisited: a meta-analysis of the published literature. Br J Cancer. 2003; 89: 1672–1685.
  • 35
    Izevbigie EB. Discovery of water-soluble anticancer agents (edotides) from a vegetable found in Benin City, Nigeria. Exp Biol Med (Maywood). 2003; 228: 293–298.
  • 36
    Adebamowo CA, Ogundiran TO, Adenipekun AA, Oyesegun RA, Campbell OB, Akang EE, et al. Waist-hip ratio and breast cancer risk in urbanized Nigerian women. Breast Cancer Res. 2003; 5: R18–24.
  • 37
    Ziegler RG, Hoover RN, Pike MC, Hildesheim A, Nomura AM, West DW, et al. Migration patterns and breast cancer risk in Asian-American women. J Natl Cancer Inst. 1993; 85: 1819–1827.
  • 38
    Amir H, Azizi MR, Makwaya CK, Jessani S. TNM classification and breast cancer in an African population: a descriptive study. Cent Afr J Med. 1997; 43: 357–359.
  • 39
    Hassan I, Muhammed I, Attah MM, Mabogunje O. Breast cancer during pregnancy and lactation in Zaria, Nigeria. East Afr Med J. 1995; 72: 280–282.
  • 40
    Dansey RD, Hessel PA, Browde S, Lange M, Derman D, Nissenbaum M, et al. Lack of a significant independent effect of race on survival in breast cancer. Cancer. 1988; 61: 1908–1912.
    Direct Link:
  • 41
    Ikpatt OF, Kuopio T, Collan Y. Proliferation in African breast cancer: biology and prognostication in nigerian breast cancer material. Mod Pathol. 2002; 15: 783–789.
  • 42
    Bjerregaard B, Kung'u A. Breast cancer in Kenya: a histopathologic and epidemiologic study. East Afr Med J. 1992; 69: 22–26.
  • 43
    Ikpatt F, Kuopio T, Erekul A, Collan Y. Apoptosis in breast cancer: Nigerian vs. Finnish material. Anal Quant Cytol Histol. 2002; 24: 73–80.
  • 44
    Ikpatt OF, Kuopio T, Ndoma-Egba R, Collan Y. Breast cancer in Nigeria and Finland: epidemiological, clinical and histological comparison. Anticancer Res. 2002; 22: 3005–3012.
  • 45
    Gao Q, Adebamowo CA, Fackenthal J, Das S, Sveen L, Falusi AG, et al. Protein truncating BRCA1 and BRCA2 mutations in African women with pre-menopausal breast cancer. Hum Genet. 2000; 107: 192–194.
  • 46
    Szabo CI, King MC. Population genetics of BRCA1 and BRCA2. Am J Hum Genet. 1997; 60: 1013–1020.
  • 47
    Yamauchi H, Stearns V, Hayes DF. When is a tumor marker ready for prime time? A case study of c-erbB-2 as a predictive factor in breast cancer. J Clin Oncol. 2001; 19: 2334–2356.
  • 48
    Xie D, Shu X. Population-based, case-control study of HER2 genetic polymorphism and breast cancer risk. J Natl Cancer Inst. 2000; 92: 412–417.
  • 49
    Ameyaw M, Thornton N, McLeod H. Re: Population-based, case-control study of HER2 genetic polymorphism and breast cancer risk. J Natl Cancer Inst. 2000; 92: 1947.
  • 50
    World Health Organization. World Health Organization per capita health care expenditures, vol. 2004. Geneva, Switzerland: World Health Organization. URL: http://www.who.int/en, [Accessed, 2004].
  • 51
    Othieno-Abinya NA, Nyabola LO, Abwao HO, Ndege P. Postsurgical management of patients with breast cancer at Kenyatta National Hospital. East Afr Med J. 2002; 79: 156–162.
  • 52
    Harder H. Role of ovarian ablation for premenopausal patients in adjuvant systemic therapy of breast cancer. Trop Doct. 1996; 26: 85.
  • 53
    Odusanya OO, Tayo OO. Breast cancer knowledge, attitudes and practice among nurses in Lagos, Nigeria. Acta Oncol. 2001; 40: 844–848.
  • 54
    Odusanya OO. Breast cancer: knowledge, attitudes, and practices of female schoolteachers in Lagos, Nigeria. Breast J. 2001; 7: 171–175.
    Direct Link:
  • 55
    Ohaeri JU, Campbell OB, Ilesanmi A, Ohaeri BM. The opinion of caregivers of some women with breast and cervical cancer on aspects of the disease. West Afr J Med. 1999; 18: 6–12.
  • 56
    Nzarubara RG. Control of breast cancer using health education. East Afr Med J. 1999; 76: 661–663.
  • 57
    Pillay A. Rural and urban South Africa women's awareness of cancers of the breast and cervix. Ethn Health. 2002; 7: 103–114.
  • 58
    Amir H, Kaaya EE, Kwesigabo G, Kiitinya JN. Breast cancer before and during the AIDS epidemic in women and men: a study of Tanzanian Cancer Registry Data 1968 to 1996. J Natl Med Assoc. 2000; 92: 301–305.
  • 59
    Guth AA. Breast cancer and human immunodeficiency virus infection: issues for the 21st century. J Womens Health (Larchmt). 2003; 12: 227–232.
  • 60
    Black WC, Welch HG. Advances in diagnostic imaging and overestimations of disease prevalence and the benefits of therapy. N Engl J Med. 1993; 328: 1237–1243.
  • 61
    Zahl PH, Strand BH, Maehlen J. Incidence of breast cancer in Norway and Sweden during introduction of nationwide screening: prospective cohort study. BMJ. 2004; 328: 921–924.
  • 62
    Pathak DR, Osuch JR, He J. Breast carcinoma etiology: current knowledge and new insights into the effects of reproductive and hormonal risk factors in black and white populations. Cancer. 2000; 88(5 Suppl ): 1230–1238.
    Direct Link:
  • 63
    Palmer JR, Wise LA, Horton NJ, Adams-Campbell LL, Rosenberg L. Dual effect of parity on breast cancer risk in African-American women. J Natl Cancer Inst. 2003; 95: 478–483.
  • 64
    Ursin G, Bernstein L, Wang Y, Lord SJ, Deapen D, Liff JM, et al. Reproductive factors and risk of breast carcinoma in a study of white and African-American women. Cancer. 2004; 101: 353–362.
    Direct Link:
  • 65
    Althuis MD, Fergenbaum JH, Garcia-Closas M, Brinton LA, Madigan MP, Sherman ME. Etiology of hormone receptor-defined breast cancer: a systematic review of the literature. Cancer Epidemiol Biomarkers Prev. 2004; 13: 1558–1568.
  • 66
    Wohlfahrt J, Andersen PK, Mouridsen HT, Adami HO, Melbye M. Reproductive history and stage of breast cancer. Am J Epidemiol. 1999; 150: 1325–1330.
  • 67
    Newman LA, Mason J, Cote D, Vin Y, Carolin K, Bouwman D, et al. African-American ethnicity, socioeconomic status, and breast cancer survival: a meta-analysis of 14 studies involving over 10,000 African-American and 40,000 White American patients with carcinoma of the breast. Cancer. 2002; 94: 2844–2854.
    Direct Link:
  • 68
    Ijaduola TG, Smith EB. Pattern of breast cancer among white-American, African-American, and nonimmigrant west-African women. J Natl Med Assoc. 1998; 90: 547–551.
  • 69
    Olopade OI FJ, Dunston G, Tainsky MA, Collins F, Whitfield-Broome C. Breast cancer genetics in African Americans. Cancer. 2002; 97(1 Suppl ): 236–245.
  • 70
    Mefford HC, Baumbach L, Panguluri RC, Whitfield-Broome C, Szabo C, Smith S, et al. Evidence for a BRCA1 founder mutation in families of West African ancestry. Am J Hum Genet. 1999; 65: 575–578.
  • 71
    Panguluri RC BL, Modali R, Utley K, Adams-Campbell L, Day AA, Whitfield-Broome C, Dunston GM. BRCA mutations in African Americans. Hum Genet. 1999; 105: 28–31.
  • 72
    Gao Q, Tomlinson G, Das S, Cummings S, Sveen L, Fackenthal J, et al. Prevalence of BRCA1 and BRCA2 mutations among clinic-based African American families with breast cancer. Hum Genet. 2000; 107: 186–191.
View Full Article (HTML) Get PDF (234K)